| Zacks Company Profile for Aksys Ltd. (AKSY : OTC) |
|
|
| |
| • Company Description |
| Aksys, Ltd. has developed an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes; and to thereby improve clinical outcomes, reduce total ESRD treatment costs and enhance the quality of life of patients. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. It also provides various services, including the delivery and installation of the PHD System.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.00 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 0 shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: 48.86 |
| 52 Week High: $ |
| 52 Week Low: $ |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
0.00% |
12.62% |
| 12 Week |
0.00% |
9.93% |
| Year To Date |
% |
% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
TWO MARRIOTT DRIVE
-
LINCOLNSHIRE,IL 60069
USA |
ph: 847-247-6051
fax: 847-229-2080 |
None |
http://www.aksys.com |
|
|
| |
| • General Corporate Information |
Officers
Richard B. Egen - Chairman of the Board of Directors
Laurence P. Birch - Chief Executive Officer; C.F.O; interim President
Lawrence D. Damron - Director
Alan R. Meyer - Director
Bernard R. Tresnowski - Director
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 010196103
SIC: 3845
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 48.86
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
